Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Quintiles has received the prestigious 2013 Informatica Innovation Award for “Enterprise Data Integration” recognizing its pioneering efforts, through the Quintiles Infosario® solution, to integrate and master both clinical research and healthcare ...
read more
For the second consecutive year, Quintiles has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress now under way in Washington, D.C., the awards recognize and ...
read more
Quintiles, the world’s leading global biopharmaceutical services company, today announced that it has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012. Presented at the World Vaccine Congress ...
read more
Friday, November 15, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
read more
Thursday, November 28, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities. This investment is a direct response to the rapid rate of adoption of the Company’s Translational Pharmaceutics ...
read more
Monday, February 24, 2020
TriNetX announced Raremark, a patient data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to the community.
read more
Wednesday, February 13, 2013
Recipharm and PledPharma announce FDA approval of an IND application for Phase IIb clinical trial with PledOx, PLIANT, in the U.S. The material for PLIANT has been manufactured by Recipharm Pharmaceutical Development.
read more
U-Protein Express announced the availability of its new recombinant SARS-CoV-2 proteins, and other proteins associated with COVID-19, for use by researchers globally.
read more
Wednesday, October 21, 2020
Recombinetics has partnered with American Preclinical Services in a first of its kind study to improve Glioblastoma outcomes.
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced that it has expanded the clinical ...
read more
ReiThera, Leukocare, and Univercells announced a collaboration for the development and largescale manufacturing of a novel adenoviral vector-based vaccine against COVID-19.
read more
Thursday, November 28, 2013
ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets.
read more
ResearchDx, LLC of Irvine, California today is pleased to announce the purchase, build-out and relocation to our state of the art 30,000 sq. foot facility in Irvine California. The custom designed facility will support our continued expansion of in ...
read more
Monday, November 16, 2020
RhoFED was awarded a contract from the BARDA, part of the Office of the Assistant Secretary for Preparedness and Response at the HHS to manage a SDCC for BARDA’s Medical Countermeasures Clinical Studies Network.
read more
Rho, a full-service contract research organization (CRO), announced its Human Epidemiology and Response to SARS-CoV-2 (HEROS) study, to help determine the rate of the new coronavirus infection in children and their families in the U.S. has been ...
read more